Regulus TherapeuticsRGLS
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$1.79avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Regulus Therapeutics Inc. (RGLS) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was NEA Management Company, LLC ($11.6M).
- Company
- Regulus Therapeutics Inc.
- CUSIP
- 75915K200
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| NEA Management Company, LLC | 0.87% | No change | 6,467,802 | $11.6M |
"% of holder's portfolio" is RGLS's weight in each manager's 13F, not the share of Regulus Therapeutics Inc. the manager owns.